Amarin Corp Plc (AMRN)

[ziploc_1]

JR...I agree...Kaiser will need to be out in force to defend Mitigate against the naysayers, who will surely come on to the scene again, including the Lovaza and Omega 3 fans....It is not the inferior generics, who are Vascepa's largest competitors...It's these other useless drugs, whose main reason for support by patients and Docs is that they are more cheap.(even if ineffective)